25.3 C
New York
Saturday, June 13, 2026

Tag: LIO

newssourceFORcompanyinformationcontent1marketreleases

FDA approves Lilly’s EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis

EBGLYSS is now the only approved option that offers as few as six maintenance injections per year with no required topicals from the startINDIANAPOLIS,...

Alpha Global partners with LIO to redefine Mental Health Care in Australia

New platform boosts patient experience and safety, reduces clinician burden, and unlocks operational insight across inpatient mental health hospitals SYDNEY, Aug. 13, 2025 /PRNewswire/ --...

LIO Launches Next-Generation Inpatient Mental Health Platform with Advanced Rounding, Monitoring, and Compliance Tools

The platform’s capabilities will support frontline staff and facility leaders, and promote patient safety 
The platform’s capabilities will support frontline staff and facility leaders, and promote patient safety

Oxehealth Rebrands as LIO, Launching Next-Gen Platform to Transform Inpatient Mental Health Care

New capabilities boost patient experience and safety, reduce clinician burden and unlock operational insight across hospitals OXFORD, England, Aug. 13, 2025 /PRNewswire/ -- Oxehealth, a...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLIO

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers